Where Molnlycke monitoring runs across care settings worldwide
Compare regional registration pathways and care-setting constraints before you expand telemetry, ICU, or remote-care fleets.
United States — FDA cleared pathways
Hospital and IDN deployments emphasize 510(k) substantial equivalence summaries, UDI receiving, GPO contracting (Premier, Vizient, HealthTrust, Intalere), Epic/Cerner HL7 FHIR messaging validation, and clinical evaluation report (CER) excerpts for value-analysis packets. Typical buyers: ICU directors, biomed, nursing informatics.
European Union — CE marked under MDR 2017/745
Tenders request Declarations of Conformity, Notified Body certificates, PMS/PMCF summaries, and GDPR-conformant data handling for connected monitors and remote-care platforms.
United Kingdom — UKCA / NHS frameworks
NHS Trust evaluations focus on UKCA status, NHS Supply Chain alignment, alarm philosophy compatibility, and service coverage across multi-site trusts.
Japan — PMDA registration
Hospital groups require PMDA-approved configurations, Japanese IFU, and authorized importer pathways before central-station expansion.
China — NMPA clearance
Tier 2/3 hospital networks evaluate NMPA-cleared SKUs, local service density, and cybersecurity filing expectations for networked monitors.
ASEAN — multi-country hospital networks
Regional groups across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines weigh registration status, language IFUs, and parts logistics.
Illustrative distribution for capacity planning
Percentages are planning illustrations for discussion, not audited Molnlycke market-share claims.
Looking to deploy monitoring in a new region?
We support FDA / CE-MDR / UKCA / PMDA / NMPA registration assistance discussions and local service mapping.